ClearPoint Neuro, Inc. (CLPT) Gross Margin
- Gross margin · 12 months: Value 62.61%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 62.61% | Gross profit / revenue. Period ending 2026-06-30. $26.47M ÷ $42.28M × 100 ≈ 62.61% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 26.47M USD | Gross Profit |
| Revenue | 42.28M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $26.47M | $42.28M | (m) | 62.61% |
| 2026-03-31 | $25.32M | $40.61M | (m) | 62.33% |
| 2025-12-31 | $22.69M | $36.97M | (m) | 61.38% |
| 2025-09-30 | $21.05M | $34.33M | (m) | 61.31% |
| 2025-06-30 | $20.30M | $33.59M | (m) | 60.42% |
| 2025-03-31 | $19.73M | $32.24M | (m) | 61.20% |
| 2024-12-31 | $19.12M | $31.39M | (m) | 60.92% |
| 2024-09-30 | $18.37M | $30.43M | (m) | 60.38% |
| 2024-06-30 | $16.80M | $28.07M | (m) | 59.85% |
| 2024-03-31 | $14.94M | $26.16M | (m) | 57.10% |
| 2023-12-31 | $13.61M | $23.95M | (m) | 56.83% |
| 2023-09-30 | $12.97M | $22.32M | (m) | 58.10% |
| 2023-06-30 | $13.37M | $21.70M | (m) | 61.62% |
| 2023-03-31 | $13.50M | $20.95M | (m) | 64.44% |
| 2022-12-31 | $13.53M | $20.55M | (m) | 65.84% |
| 2022-09-30 | $13.57M | $19.66M | (m) | 69.01% |
| 2022-06-30 | $12.91M | $19.09M | (m) | 67.62% |
| 2022-03-31 | $11.92M | $17.30M | (m) | 68.92% |
| 2021-12-31 | $11.29M | $16.30M | (m) | 69.27% |
| 2021-09-30 | (m) | $15.73M | (m) | (m) |
| 2021-06-30 | (m) | $14.68M | (m) | (m) |
| 2021-03-31 | (m) | $13.74M | (m) | (m) |
| 2020-12-31 | (m) | $12.83M | (m) | (m) |
| 2020-09-30 | (m) | $12.32M | (m) | (m) |
| 2020-06-30 | (m) | $11.73M | (m) | (m) |
| 2020-03-31 | (m) | $11.86M | (m) | (m) |
| 2019-12-31 | (m) | $11.22M | (m) | (m) |
| 2019-09-30 | (m) | $10.28M | (m) | (m) |
| 2019-06-30 | (m) | $9.16M | (m) | (m) |
| 2019-03-31 | (m) | $8.20M | (m) | (m) |
| 2018-12-31 | (m) | $7.35M | (m) | (m) |
| 2018-09-30 | (m) | $6.76M | (m) | (m) |
| 2018-06-30 | (m) | $6.67M | (m) | (m) |
| 2018-03-31 | (m) | $7.00M | (m) | (m) |
| 2017-12-31 | (m) | $7.38M | (m) | (m) |
| 2017-09-30 | (m) | $7.34M | (m) | (m) |
| 2017-06-30 | (m) | $7.23M | (m) | (m) |
| 2017-03-31 | (m) | $6.36M | (m) | (m) |
| 2016-12-31 | (m) | $5.75M | (m) | (m) |
| 2016-09-30 | (m) | $5.63M | (m) | (m) |
| 2016-06-30 | (m) | $5.26M | (m) | (m) |
| 2016-03-31 | (m) | $4.98M | (m) | (m) |
| 2015-12-31 | (m) | $4.59M | (m) | (m) |
| 2015-09-30 | (m) | $4.04M | (m) | (m) |
| 2015-06-30 | (m) | $3.43M | (m) | (m) |
| 2015-03-31 | (m) | $3.79M | (m) | (m) |
| 2014-12-31 | (m) | $3.60M | (m) | (m) |
| 2014-09-30 | (m) | $3.82M | (m) | (m) |
| 2014-06-30 | (m) | $4.12M | (m) | (m) |
| 2014-03-31 | (m) | $3.49M | (m) | (m) |
| 2013-12-31 | (m) | $3.93M | (m) | (m) |
| 2013-09-30 | (m) | $4.62M | (m) | (m) |
| 2013-06-30 | (m) | $4.82M | (m) | (m) |
| 2013-03-31 | (m) | $5.34M | (m) | (m) |
| 2012-12-31 | (m) | $5.06M | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $3.82M | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $2.67M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |